These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26548523)

  • 1. Protein-protein interactions of the LIM-only protein FHL2 and functional implication of the interactions relevant in cardiovascular disease.
    Tran MK; Kurakula K; Koenis DS; de Vries CJ
    Biochim Biophys Acta; 2016 Feb; 1863(2):219-28. PubMed ID: 26548523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
    Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
    Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
    Wang Q; Wang X; Tian X; Tang R; Xu X
    J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
    Kleiber K; Strebhardt K; Martin BT
    Anticancer Res; 2007; 27(1A):55-61. PubMed ID: 17352216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHL2: a scaffold protein of carcinogenesis, tumour-stroma interactions and treatment response.
    Verset L; Feys L; Trépant AL; De Wever O; Demetter P
    Histol Histopathol; 2016 May; 31(5):469-78. PubMed ID: 26676939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
    Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
    J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How (Epi)Genetic Regulation of the LIM-Domain Protein FHL2 Impacts Multifactorial Disease.
    Habibe JJ; Clemente-Olivo MP; de Vries CJ
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
    Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes.
    Wixler V; Geerts D; Laplantine E; Westhoff D; Smyth N; Aumailley M; Sonnenberg A; Paulsson M
    J Biol Chem; 2000 Oct; 275(43):33669-78. PubMed ID: 10906324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FHL2 regulation in the transcriptional circuitry of human cancers.
    Cao CY; Mok SW; Cheng VW; Tsui SK
    Gene; 2015 Nov; 572(1):1-7. PubMed ID: 26211626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XIAP-associated factor 1 interacts with and attenuates the trans-activity of four and a Half LIM protein 2.
    Zhang W; Yang Y; Jiang B; Peng J; Tu S; Sardet C; Zhang Y; Pang R; Hung IF; Tan VP; Lam CS; Wang J; Wong BC
    Mol Carcinog; 2011 Mar; 50(3):199-207. PubMed ID: 21104993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix mechanics controls FHL2 movement to the nucleus to activate p21 expression.
    Nakazawa N; Sathe AR; Shivashankar GV; Sheetz MP
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6813-E6822. PubMed ID: 27742790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of FHL2 in cancer.
    Zhang J; Zeng Q; She M
    Clin Exp Med; 2023 Nov; 23(7):3113-3124. PubMed ID: 37103649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The LIM-Only Protein Four and a Half LIM Domain Protein 2 Attenuates Development of Psoriatic Arthritis by Blocking Adam17-Mediated Tumor Necrosis Factor Release.
    Leite Dantas R; Brachvogel B; Schied T; Bergmeier V; Skryabin B; Vogl T; Ludwig S; Wixler V
    Am J Pathol; 2017 Nov; 187(11):2388-2398. PubMed ID: 28823868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the adaptor function of the LIM domain-containing protein FHL2 using an affinity chromatography approach.
    El Mourabit H; Müller S; Tunggal L; Paulsson M; Aumailley M
    J Cell Biochem; 2004 Jun; 92(3):612-25. PubMed ID: 15156572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.
    Labalette C; Renard CA; Neuveut C; Buendia MA; Wei Y
    Mol Cell Biol; 2004 Dec; 24(24):10689-702. PubMed ID: 15572674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
    Matulis CK; Mayo KE
    Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FHL2 protein is a novel co-repressor of nuclear receptor Nur77.
    Kurakula K; van der Wal E; Geerts D; van Tiel CM; de Vries CJ
    J Biol Chem; 2011 Dec; 286(52):44336-43. PubMed ID: 22049082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LIM-only protein FHL2 regulates interleukin-6 expression through p38 MAPK mediated NF-κB pathway in muscle cells.
    Wong CH; Mak GW; Li MS; Tsui SK
    Cytokine; 2012 Aug; 59(2):286-93. PubMed ID: 22633286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
    Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
    J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.